Autobahn Labs Revenue and Competitors
Estimated Revenue & Valuation
- Autobahn Labs's estimated annual revenue is currently $1.9M per year.
- Autobahn Labs's estimated revenue per employee is $155,000
Employee Data
- Autobahn Labs has 12 Employees.
- Autobahn Labs grew their employee count by -20% last year.
Autobahn Labs's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Head Search & Evaluation | Reveal Email/Phone |
3 | Senior Director, Drug Development | Reveal Email/Phone |
4 | Associate | Reveal Email/Phone |
Autobahn Labs Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Autobahn Labs?
Autobahn Labs is collaboration between a Samsara BioCapital-led investor syndicate and Evotec. By combining Samsara's long-term investment philosophy with Evotec’s world-class drug discovery and development capabilities we believe we can improve patient health by identifying exciting early-stage academic research projects that can spark the development of new therapeutics.
keywords:N/A
N/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
-20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Palo Alto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.6M | 12 | -8% | N/A |
#2 | $1M | 12 | N/A | N/A |
#3 | $0.9M | 12 | -57% | N/A |
#4 | $15M | 12 | 140% | N/A |
#5 | $1.2M | 12 | 0% | N/A |